These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2737813)

  • 21. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
    Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY
    Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
    Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC
    Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease.
    Ozkan Y; Yardim-Akaydin S; Sepici A; Engin B; Sepici V; Simşek B
    Clin Chem Lab Med; 2007; 45(1):73-7. PubMed ID: 17243919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in Behçet's disease and correlation with disease activity.
    Saylam Kurtipek G; Kesli R; Tuncez Akyurek F; Akyurek F; Ataseven A; Terzi Y
    Int J Rheum Dis; 2018 Apr; 21(4):866-870. PubMed ID: 27171829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of interleukin-8 in patients with Behcet's disease.
    Ozoran K; Aydintuğ O; Tokgöz G; Düzgün N; Tutkak H; Gürler A
    Ann Rheum Dis; 1995 Jul; 54(7):610. PubMed ID: 7668912
    [No Abstract]   [Full Text] [Related]  

  • 27. Von Willebrand factor antigen levels in Behçet disease.
    Beyan E; Sadikoğlu B; Ertuğrul E; Beyan C
    Am J Hematol; 2005 May; 79(1):70-2. PubMed ID: 15849757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of serum leptin concentration in Behçet's disease with ocular involvement.
    Kavuncu S; Koç F; Kurt M; Eryüksel B; Ortaç S; Ozdal P; Firat E
    Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1158-60. PubMed ID: 15906063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acid-soluble protein in Behçet's disease.
    Shimakawa M; Kogure M
    Am J Ophthalmol; 1986 Aug; 102(2):281-2. PubMed ID: 3790207
    [No Abstract]   [Full Text] [Related]  

  • 30. [The functioning of the fibrinolytic system in Behçet's syndrome].
    Asbeck F; Meyer-Boernecke D; van de Loo J
    Verh Dtsch Ges Inn Med; 1978; (84):1359-62. PubMed ID: 741967
    [No Abstract]   [Full Text] [Related]  

  • 31. [Microtubules in polymorphonuclear leukocytes from patients with Behçet's disease].
    Saga T; Matsuda H
    Nippon Ganka Gakkai Zasshi; 1985 Feb; 89(2):349-53. PubMed ID: 4003214
    [No Abstract]   [Full Text] [Related]  

  • 32. Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease.
    Haznedaroğlu IC; Ozdemir O; Ozcebe O; Dündar SV; Kirazli S
    Thromb Haemost; 1996 Jun; 75(6):974-5. PubMed ID: 8822597
    [No Abstract]   [Full Text] [Related]  

  • 33. Fractalkine (CX3CL1) levels in patients with Behçet's disease and neuro-Behçet's disease.
    Ceyla I; Tuba TK; Adisen E; Banu O; Isil F; Ali GM; Turgut I; Banu B
    J Neurol Sci; 2012 Apr; 315(1-2):120-2. PubMed ID: 22177089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma prostacyclin levels in Behçet's disease.
    Hizli N; Sahin G; Sahin F; Kansu E; Duru S; Karacadag S; Batman F; Dundar S; Zileli T; Telatar H
    Lancet; 1985 Jun; 1(8443):1454. PubMed ID: 2861400
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum neopterin levels in Behçet's syndrome.
    Keser G; Oksel F; Aksu K; Kabasakal Y; Gümüşdiş G; Doganavş argil E; Sin A
    Clin Rheumatol; 2000; 19(4):328-9. PubMed ID: 10941821
    [No Abstract]   [Full Text] [Related]  

  • 36. Behçet's disease.
    Chamberlain MA
    Br Med J; 1978 Nov; 2(6148):1369-70. PubMed ID: 719402
    [No Abstract]   [Full Text] [Related]  

  • 37. Association between red blood cell distribution width and disease activity in patients with Behçet's disease.
    Aksoy ŞN; Savaş E; Sucu M; Kisacik B; Kul S; Zengin O
    J Int Med Res; 2015 Dec; 43(6):765-73. PubMed ID: 26359293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphonuclear function in Behçet's syndrome.
    Friman C; Davis P
    Ann Rheum Dis; 1983 Aug; 42(4):477-8. PubMed ID: 6309103
    [No Abstract]   [Full Text] [Related]  

  • 39. Polymorphonuclear leukocyte elastase levels in patients with Behçet's disease.
    Değer O; Orem A; Akyol N; Bahadir S; Yildirmis S
    Clin Chim Acta; 1995 May; 236(2):129-34. PubMed ID: 7554279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute phase proteins, C9, factor B, and lysozyme in recurrent oral ulceration and Behçet's syndrome.
    Lehner T; Adinolfi M
    J Clin Pathol; 1980 Mar; 33(3):269-75. PubMed ID: 6900632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.